AU3200393A - Body tissue omega-3 fatty-acid-augmenting agent and nutrient composition containing the same - Google Patents

Body tissue omega-3 fatty-acid-augmenting agent and nutrient composition containing the same

Info

Publication number
AU3200393A
AU3200393A AU32003/93A AU3200393A AU3200393A AU 3200393 A AU3200393 A AU 3200393A AU 32003/93 A AU32003/93 A AU 32003/93A AU 3200393 A AU3200393 A AU 3200393A AU 3200393 A AU3200393 A AU 3200393A
Authority
AU
Australia
Prior art keywords
fatty
acid
composition containing
same
body tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU32003/93A
Other versions
AU666157B2 (en
Inventor
Tadashi Idota
Yumiko Ishiyama
Taku Nakano
Masaharu Shimatani
Makihiro Sugawara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Megmilk Snow Brand Co Ltd
Original Assignee
Megmilk Snow Brand Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=12727689&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU3200393(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Megmilk Snow Brand Co Ltd filed Critical Megmilk Snow Brand Co Ltd
Publication of AU3200393A publication Critical patent/AU3200393A/en
Application granted granted Critical
Publication of AU666157B2 publication Critical patent/AU666157B2/en
Assigned to MEGMILK SNOW BRAND CO., LTD. reassignment MEGMILK SNOW BRAND CO., LTD. Request to Amend Deed and Register Assignors: SNOW BRAND MILK PRODUCTS CO., LTD.
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

AU32003/93A 1992-03-03 1993-01-25 Body tissue omega-3 fatty-acid-augmenting agent and nutrient composition containing the same Expired AU666157B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP4-45739 1992-03-03
JP04573992A JP3173844B2 (en) 1992-03-03 1992-03-03 Agent for increasing ω3 fatty acid in living tissue and nutritional composition containing the same

Publications (2)

Publication Number Publication Date
AU3200393A true AU3200393A (en) 1993-09-09
AU666157B2 AU666157B2 (en) 1996-02-01

Family

ID=12727689

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32003/93A Expired AU666157B2 (en) 1992-03-03 1993-01-25 Body tissue omega-3 fatty-acid-augmenting agent and nutrient composition containing the same

Country Status (2)

Country Link
JP (1) JP3173844B2 (en)
AU (1) AU666157B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9504712B2 (en) 2001-11-14 2016-11-29 N.V. Nutricia Preparation for improving the action of receptors
CN115227706A (en) * 2022-06-08 2022-10-25 珍奥集团股份有限公司 Application of 5' -monophosphate nucleotide composition in preparation of fat-reducing and weight-losing functional food and medicine

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100471502C (en) 2002-04-09 2009-03-25 大塚制药株式会社 Composition for cell proliferation
DE10215753A1 (en) * 2002-04-10 2003-10-30 Trommsdorff Arzneimittel Use of pyrimidine nucleotides for the treatment of damage to the peripheral nervous system
EP2554057A4 (en) * 2010-03-31 2013-12-18 Vegenat S A Enteral or oral food product intended, in particular, for nutrition and for the prevention and improvement of neurological alterations, neurodegenerative alterations or cognitive disorders
US20130172286A1 (en) * 2010-03-31 2013-07-04 Vegenat, S.A. Functional Food Supplement Intended, In Particular, For Nutrition And For Prevention And Improvement of Neurological Alterations, Neurodegenerative Alterations Or Cognitive Disorders
RU2706963C2 (en) * 2014-11-26 2019-11-21 Абботт Лаборэтриз Milk mixture containing breast milk oligosaccharides, polyunsaturated fatty acids, nucleotides and lutein
CN105982074A (en) * 2015-03-06 2016-10-05 内蒙古伊利实业集团股份有限公司 Nucleotide composition and application thereof in foods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60126220A (en) * 1983-12-09 1985-07-05 Otsuka Pharmaceut Factory Inc Nucleic acid component composition
ES2007350A6 (en) * 1987-05-29 1989-06-16 Ganadera Union Ind Agro Food products enriched with nucleosides and/or nucleotides and preparation thereof.

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9504712B2 (en) 2001-11-14 2016-11-29 N.V. Nutricia Preparation for improving the action of receptors
US9844525B2 (en) 2001-11-14 2017-12-19 N.V. Nutricia Preparation for improving the action of receptors
CN115227706A (en) * 2022-06-08 2022-10-25 珍奥集团股份有限公司 Application of 5' -monophosphate nucleotide composition in preparation of fat-reducing and weight-losing functional food and medicine
CN115227706B (en) * 2022-06-08 2023-12-29 陈玉松 Application of nucleotide 5' -monophosphate composition in preparation of fat-reducing and weight-losing functional foods and medicines

Also Published As

Publication number Publication date
JP3173844B2 (en) 2001-06-04
JPH05252899A (en) 1993-10-05
AU666157B2 (en) 1996-02-01

Similar Documents

Publication Publication Date Title
AU1231395A (en) Body conforming absorbent article
AU2971292A (en) Body fluid absorbent article
AU673703B2 (en) Injector and use of the same
AU626396B2 (en) Composition and use
HUP0000474A3 (en) Arylethenesulfonamide derivatives and drug composition containing the same
AU6437394A (en) Thiazolidine derivative and pharmaceutical composition containing the same
AU2105388A (en) Absorbent structures with gelling agent and absorbent articles containing such structures
AU5562494A (en) Alkylglyceramides and their use as surfactants
AU6959694A (en) Antineoplastic compositions and methods of use
AU3959193A (en) Heterocyclic compounds and their use in the treatment of type II-diabetes
AU2630295A (en) 2-acylaminopropanol compound and medical composition
AU1545495A (en) Therapeutic composition for replacing and/or supplementing body fluids
AU4520893A (en) Sterilization process and composition
AU6983894A (en) Thiazolidine derivative and medicine containing the same
AU5465594A (en) Aldonamides and their use as surfactants
GB9504040D0 (en) Arylsulfonamide derivative and pharmaceutical composition containing the same
AU639845B2 (en) Antimicrobial composition and use
AU3502789A (en) Composition and use
AU3200393A (en) Body tissue omega-3 fatty-acid-augmenting agent and nutrient composition containing the same
AU3805593A (en) Phosphate selective composition and electrode
AU4563093A (en) Echographic contrast agent composition
AU4243389A (en) Antimicrobial composition and method of use
AU4468093A (en) Composition and methods for the generation of bone
AU4118393A (en) Human crabp-I and crabp-II
AU7476494A (en) Use of n-methyl-aspartic acid for enhancing growth and altering body composition